A novel targeted oral insulin-like growth factor-1 receptor (IGF-1R) inhibitor and its implications for patients with non-small cell lung cancer (NSCLC): A phase I clinical trial

作者:Ekman Simon; Harmenberg Johan; Frodin Jan Erik; Bergstrom Stefan; Was**erg Cecilia; Ek**org Staffan; Larsson Olle; Axelson Magnus; Hedlund Asa; Alvfors Carina; Stahl Birgitta; Bergqvist Michael
来源:48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2012-06-01 to 2012-06-06.
  • 出版日期2012-5-20